Previous 10 | Next 10 |
home / stock / nonof / nonof news
2024-05-20 08:20:00 ET Summary The mean weight loss in a Phase 1b trial of the GLP/GIP against CT-388 (once-a-week injection for 24 weeks) has just read out at 18.8%, with (apparently) no safety signals. Amgen sort-of-announced positive results on its candidate, MariTide. Boeh...
2024-05-18 14:52:07 ET More on GSK, Johnson & Johnson, etc. Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript) Johnson & Johnson (JNJ) ...
2024-05-15 09:34:32 ET More on Danaher, Novo Nordis, etc. Danaher Corporation (DHR) Presents at BofA Securities 2024 Health Care Conference Call Transcript The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation ...
2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...
2024-05-14 14:42:53 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Novo Nordisk: Patients on Wegovy maintain weight ...
2024-05-11 12:13:54 ET More on Fresenius Medical Care Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcr...
2024-05-10 10:16:35 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Dividend Roundup: Eli Lilly, A...
2024-05-02 12:21:14 ET Novo Nordisk A/S (NVO) Q1 2024 Earnings Conference Call May 2, 2024 07:00 a.m. ET Company Participants Lars Fruergaard Jørgensen - Chief Executive Officer Camilla Sylvest - Executive Vice President, Head of Commercial Strategy & Corpor...
2024-05-02 01:40:07 ET More on Novo Nordisk: Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy Novo Nordisk Remains The Better Buy After A Moderate Pullback Novo Nordisk: The Moat Won't Last Forever Novo, Teva, AstraZeneca issued FTC war...
2024-05-01 17:07:44 ET Summary Amgen Inc. shares have dropped some 20% since reaching an all-time high in February due to a below-consensus outlook and patent concerns. The company's four pillars of growth are General Medicine, Oncology, Inflammatory Diseases, and Rare Diseases. ...
News, Short Squeeze, Breakout and More Instantly...
Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation and cell therapy development and manufacturing . Aspect to receive 75 million US dollars in initial payments and u...
New York City, NY: May 06, 2020 – Published via (Wired Release):- “Market.us presents a new report titled Alkyl Benzyl Dimethyl Ammonium Chloride Market: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information...